Training in Molecular Therapeutics for Pediatric Cardiology

儿科心脏病学分子治疗培训

基本信息

  • 批准号:
    8460017
  • 负责人:
  • 金额:
    $ 40.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-07-01 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

Description (provided by applicant): This training program provides two years of basic research training in vascular surgery for academic clinicians. It addresses the absence of adequate research training for vascular surgeons as it applies to specific areas of clinical disease. Research training in molecular and cell biology, biomechanics, coagulation thrombosis, and angiogenesis is provided with a focus on clinically relevant problems such as atherogenesis, intimal hyperplasia, prosthetic/host interactions and thrombosis. A new component is the availability of mentored advanced outcomes research training Trainees pursue a program of intense research activity supplemented with course work in research design, statistics, and evaluation of published research. The program is conducted and closely supervised by the program director, co-director and mentors who have well-established records of peer-reviewed research, and who were selected both for the current research activities and their proven commitment to train research fellows. Individual mentors are chosen from the program's faculty on the basis of the background and research interest of the individual trainee, and the trainees carry out their own projects under the close guidance of their mentor. Laboratory training can be supplemented by graduate level training at Harvard Medical School the Department of Health Care Policy and Research and Harvard's Faculty of Arts and Sciences, with course selection complementing laboratory endeavors. Upon completion of the program, trainees are capable of independent research and possess the scientific and research background needed to obtain competitive peer-reviewed grants; they have the abilities and knowledge necessary to provide translational expertise as they join medical school faculties. Selection of the trainees is based on candidates' demonstrated ability and career choice of academic practice. Applicants are resident physicians who have completed two, three or five years (i.e. is board eligible) of post-graduate surgical training. Trainees commit to two years of training; trainees desiring a shorter training period are not considered. Only those applicants with career goals in academic surgery, with a keen interest in basic resarch or outcomes research in vascular surgery, are compatible. Candidates pursuing a fellowship during a program of clinical traning must provide evidence that they will be accepted back into that program upon completion of their research training. Trainees are not involved in any clinical activities unless research related. RELEVANCE (See instructions): Vascular Surgeons provide a practical "hands on" perspective on the relevant problems of devices and interventions on blood vessels. This program creates a cadre of surgeons with expertise in research fundamentals essential to frontline 'bench to bedside to public policy' programs in treatment of vascular disease.
描述(由申请人提供):该培训计划为学术临床医生提供两年的血管外科基础研究培训。它解决了血管外科医生缺乏足够的研究培训,因为它适用于临床疾病的特定领域。提供分子和细胞生物学、生物力学、凝血血栓形成和血管生成方面的研究培训,重点是临床相关问题,如动脉粥样硬化形成、内膜增生、假体/宿主相互作用和血栓形成。一个新的组成部分是辅导先进的成果研究培训的可用性学员追求密集的研究活动的计划,辅以研究设计,统计和发表的研究评估课程工作。该计划由计划主任,联合主任和导师进行并密切监督,他们拥有同行评审研究的良好记录,并且被选为当前的研究活动和他们对培训研究员的承诺。个别导师是根据个别学员的背景和研究兴趣从该计划的教师中选出的,学员在导师的密切指导下开展自己的项目。实验室培训可以通过哈佛医学院卫生保健政策和研究系以及哈佛文理学院的研究生水平培训来补充,课程选择补充实验室工作。完成该计划后,学员能够独立研究,并拥有获得竞争性同行评审赠款所需的科学和研究背景;他们拥有必要的能力和知识,在加入医学院时提供翻译专业知识。学员的甄选是基于候选人的学术实践能力和职业选择。申请人是住院医师谁已经完成了两年,三年或五年(即董事会资格)的研究生外科培训。受训者承诺接受两年的培训;希望接受较短培训期的受训者不予考虑。只有那些在学术外科的职业目标,在血管外科的基础研究或成果研究的浓厚兴趣的申请人,是兼容的。在临床培训计划期间寻求奖学金的候选人必须提供证据,证明他们在完成研究培训后将被该计划接受。受训人员不参与任何临床活动,除非与研究相关。相关性(参见说明):血管外科医生提供了一个实际的“动手”的角度对有关问题的设备和干预血管。该计划创造了一个外科医生的骨干,具有研究基础知识的专业知识,对血管疾病治疗的一线“从板凳到床边到公共政策”计划至关重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert J Levy其他文献

137 STUDIES ON THE PATHOGENESES Of CALCIFIC AORTIC VALUE DISEASE: THE ROLE OF THE CALCIUM BINDING AMINO ACID δ CARBOXYGLUTAMIC ACID
137 关于钙化性主动脉瓣疾病发病机制的研究:钙结合氨基酸δ羧基谷氨酸的作用
  • DOI:
    10.1203/00006450-197804001-00142
  • 发表时间:
    1978-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Robert J Levy;Jane B Lian;Paul M Gallop
  • 通讯作者:
    Paul M Gallop
Anchoring of self-assembled plasmid DNA/ anti-DNA antibody/cationic lipid micelles on bisphosphonate-modified stent for cardiovascular gene delivery
将自组装质粒 DNA/抗 DNA 抗体/阳离子脂质胶束锚定在双磷酸盐修饰支架上用于心血管基因递送
260 STUDIES ON A NEW COAGULATION PARAMETER: DECREASED URINARY X CARBOXYGLUTAMIC ACID EXCRETION WITH WARFARIN THERAPY
  • DOI:
    10.1203/00006450-197804001-00265
  • 发表时间:
    1978-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Robert J Levy;Jane D Lian;Paul M Gallop
  • 通讯作者:
    Paul M Gallop
PSS273 - Oxidation-mediated Mechanisms of Bioprosthetic Heart Valve Failure
  • DOI:
    10.1016/j.freeradbiomed.2013.10.697
  • 发表时间:
    2013-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Abigail J Christian;Hongqiao Lin;Ivan Alferiev;Stanley L Hazen;Harry Ischiropoulos;Robert J Levy
  • 通讯作者:
    Robert J Levy
INHIBITION OF BIOPROSTHETIC (BHV) CALCIFICATION (CALL) WITH COVALENTLY BOUND AMINOPROPANEHYDROXYDIPHOSPHONATE (APD)
用共价结合的氨基丙基羟二膦酸盐(APD)抑制生物假体(BHV)钙化(CALL)
  • DOI:
    10.1203/00006450-198704010-00177
  • 发表时间:
    1987-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Catherine L Webb;James Benedict;Judy Linden;Robert J Levy
  • 通讯作者:
    Robert J Levy

Robert J Levy的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert J Levy', 18)}}的其他基金

Medical Device Consortium at the Children's Hospital of Philadelphia
费城儿童医院医疗器械联盟
  • 批准号:
    10683865
  • 财政年份:
    2018
  • 资助金额:
    $ 40.13万
  • 项目类别:
Medical Device Consortium at the Children's Hospital of Philadelphia
费城儿童医院医疗器械联盟
  • 批准号:
    9768955
  • 财政年份:
    2018
  • 资助金额:
    $ 40.13万
  • 项目类别:
Medical Device Consortium at the Children's Hospital of Philadelphia
费城儿童医院医疗器械联盟
  • 批准号:
    10466822
  • 财政年份:
    2018
  • 资助金额:
    $ 40.13万
  • 项目类别:
Medical Device Consortium at the Children's Hospital of Philadelphia
费城儿童医院医疗器械联盟
  • 批准号:
    10468507
  • 财政年份:
    2018
  • 资助金额:
    $ 40.13万
  • 项目类别:
Medical Device Consortium at the Children's Hospital of Philadelphia
费城儿童医院医疗器械联盟
  • 批准号:
    10247486
  • 财政年份:
    2018
  • 资助金额:
    $ 40.13万
  • 项目类别:
High Field Gradient Targeting Magnetic Nanoparticle Loaded Cells to Stents
高场梯度将磁性纳米粒子负载细胞靶向支架
  • 批准号:
    8103513
  • 财政年份:
    2011
  • 资助金额:
    $ 40.13万
  • 项目类别:
High Field Gradient Targeting Magnetic Nanoparticle Loaded Cells to Stents
高场梯度将磁性纳米粒子负载细胞靶向支架
  • 批准号:
    8270523
  • 财政年份:
    2011
  • 资助金额:
    $ 40.13万
  • 项目类别:
TGA-ethanol Pretreated Bovine Pericardium for the Norwood Procedure
用于诺伍德手术的 TGA-乙醇预处理牛心包
  • 批准号:
    7867658
  • 财政年份:
    2010
  • 资助金额:
    $ 40.13万
  • 项目类别:
TGA-ethanol Pretreated Bovine Pericardium for the Norwood Procedure
用于诺伍德手术的 TGA-乙醇预处理牛心包
  • 批准号:
    8013820
  • 财政年份:
    2010
  • 资助金额:
    $ 40.13万
  • 项目类别:
Blood Outgrowth Endothelial Cell Seeding of Heart Valve Leaflets
心脏瓣膜小叶的血液生长内皮细胞接种
  • 批准号:
    7894729
  • 财政年份:
    2009
  • 资助金额:
    $ 40.13万
  • 项目类别:

相似海外基金

Molecular design of Two-Way Player CAR-T cells to overcome disease/antigen heterogeneity of childhood, adolescent, and young adult cancers
双向 CAR-T 细胞的分子设计,以克服儿童、青少年和年轻成人癌症的疾病/抗原异质性
  • 批准号:
    23H02874
  • 财政年份:
    2023
  • 资助金额:
    $ 40.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identifying molecular pathways in childhood asthma pathogenesis by integrating newborn metabolic profiles and GWAS data
通过整合新生儿代谢特征和 GWAS 数据来确定儿童哮喘发病机制的分子途径
  • 批准号:
    10612834
  • 财政年份:
    2022
  • 资助金额:
    $ 40.13万
  • 项目类别:
Identifying molecular pathways in childhood asthma pathogenesis by integrating newborn metabolic profiles and GWAS data
通过整合新生儿代谢特征和 GWAS 数据来确定儿童哮喘发病机制的分子途径
  • 批准号:
    10349034
  • 财政年份:
    2022
  • 资助金额:
    $ 40.13万
  • 项目类别:
Benchmarking non-invasive genomic tools for molecular subtyping of childhood leukemias
用于儿童白血病分子分型的非侵入性基因组工具的基准测试
  • 批准号:
    564039-2021
  • 财政年份:
    2021
  • 资助金额:
    $ 40.13万
  • 项目类别:
    University Undergraduate Student Research Awards
Elucidation of Molecular Pathogenesis in Childhood-Onset Liver Failure
阐明儿童期肝衰竭的分子发病机制
  • 批准号:
    20K08251
  • 财政年份:
    2020
  • 资助金额:
    $ 40.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM
儿童癌症数据倡议:临床试验样本分子表征 (CTSMC) 计划
  • 批准号:
    10281333
  • 财政年份:
    2020
  • 资助金额:
    $ 40.13万
  • 项目类别:
Molecular pathophysiology of food allergy in early childhood
儿童早期食物过敏的分子病理生理学
  • 批准号:
    20K08809
  • 财政年份:
    2020
  • 资助金额:
    $ 40.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM
儿童癌症数据倡议:临床试验样本分子表征 (CTSMC) 计划
  • 批准号:
    10787973
  • 财政年份:
    2020
  • 资助金额:
    $ 40.13万
  • 项目类别:
Molecular pathogenesis and novel therapeutic strategy for osteonecrosis of the femoral head in childhood from the view of interleukin-6
从IL-6角度探讨儿童股骨头坏死的分子发病机制及治疗新策略
  • 批准号:
    19K09563
  • 财政年份:
    2019
  • 资助金额:
    $ 40.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular and Functional Characterization of Childhood Ependymoma
儿童室管膜瘤的分子和功能特征
  • 批准号:
    381502
  • 财政年份:
    2018
  • 资助金额:
    $ 40.13万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了